ClinicalTrials.gov
public full text
Public Domain
Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP
Breakthrough cancer pain (BTcP) is a common problem in patients with cancer. This is a phase IIa dose-response and safety study of inhaled fentanyl aerosol (25µg/dose) in Chinese patients with breakthrough cancer pain.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain#845289
- A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors#895972
- Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain#877729
- Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea#1350571
- Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose#1309207
Record · ID 1452876
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive